Arterial Ischemia
|
Top Associated Network Functions |
|
|
|
Infectious Disease, antigen presentation, inflammatory response |
33 |
|
|
Cellular compromise, cellular function and maintenance, inflammatory response |
30 |
|
|
Cellular function and maintenance, cell-to-cell signaling and interaction, inflammatory response |
28 |
|
|
Cellular movement, hematological system development and function, cell-to-cell signaling and interaction |
28 |
|
|
Cellular movement, hematological system development and function, immune cell trafficking |
25 |
|
|
Top biological functions |
|
|
|
Inflammatory response |
|
1.02E-21–1.48×10−04
|
108 |
Inflammatory disease |
|
8.11E-16–1.03×10−04
|
122 |
Immunological disease |
|
9.57E-14–1.48×10−04
|
112 |
Organismal injury and abnormalities |
|
2.37E-12–1.48×10−04
|
53 |
Respiratory disease |
|
4.10E-12–1.48×10−04
|
49 |
Cellular development |
|
5.84E-24–1.52×10−04
|
112 |
Cellular movement |
|
9.35E-18–1.39×10−04
|
83 |
Cellular function and maintenance |
|
3.62E-15–1.52×10−04
|
87 |
Cell death |
|
5.26E-15–1.48×10−04
|
130 |
Cell-to-cell signaling and interaction |
|
6.45E-15–1.48×10−04
|
98 |
Hematological system development |
|
8.74E-20–1.61×10−04
|
120 |
Tissue morphology |
|
8.74E-20–7.04×10−05
|
74 |
Immune cell trafficking |
|
9.35E-18–1.61×10−04
|
79 |
Hematopoiesis |
|
2.40E-17–1.52×10−04
|
78 |
Cell-mediated Immune Response |
|
8.18E-14–1.52×10−04
|
54 |
Top Canonical Pathways |
|
|
|
Colorectal cancer metastasis signaling |
|
9.65×10−7
|
|
Type I diabetes mellitus signaling |
|
1.35×10−6
|
|
Production of nitric oxide and reactive oxygen species in macrophages |
|
1.85×10−6
|
|
Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis |
|
2.22×10−6
|
|
Role of pattern recognition receptors in recognition of bacteria and viruses |
|
2.57×10−6
|
|
Venous congestion
|
Top associated network functions |
|
|
|
Renal and urological disease, cell death, embryonic development |
41 |
|
|
Nutritional disease, immunological disease, gastrointestinal disease |
32 |
|
|
Post-translational modification, cell death, nervous system development and function |
32 |
|
|
Cell signaling, cardiovascular system development and function, connective tissue disorders |
31 |
|
|
Genetic disorder, immunological disease, cardiovascular disease |
30 |
|
|
Top biological functions |
|
|
|
Inflammatory response |
|
1.07E-28–2.44×10−07
|
262 |
Cancer |
|
4.81E-27–1.72×10−07
|
423 |
Inflammatory disease |
|
4.58E-25–2.59×10−07
|
384 |
Immunological disease |
|
7.44E-23–2.30×10−07
|
326 |
Hematological disease |
|
2.23E-17–3.17×10−07
|
250 |
Cellular movement |
|
1.94E-34–3.17×10−07
|
285 |
Cellular growth and proliferation |
|
6.15E-34–2.49×10−07
|
396 |
Cellular development |
|
7.63E-27–2.47×10−07
|
352 |
Cell death |
|
3.31E-23–2.53×10−07
|
371 |
Cell-to-cell signaling and interaction |
|
1.05E-22–2.01×10−07
|
268 |
Hematological system development and function |
|
3.36E-33–2.30×10−07
|
291 |
Immune cell trafficking |
|
3.36E-33–2.27×10−07
|
196 |
Tissue morphology |
|
4.73E-24–2.30×10−07
|
186 |
Organismal survival |
|
9.46E-23–2.05×10−08
|
201 |
Tissue development |
|
1.05E-22–2.13×10−07
|
198 |
Top Canonical Pathways |
|
|
|
Type I diabetes mellitus signaling |
|
1.05×10−10
|
|
Production of nitric oxide and reactive oxygen species in macrophages |
|
1.28×10−7
|
|
Hepatic fibrosis/hepatic stellate cell activation |
|
1.90×10−7
|
|
IL-10 signaling |
|
3.96×10−7
|
|
T helper cell differentiation |
|
5.02×10−7
|
|